ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 638066 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 638066; 2) Community: the network communities that were significantly associated with the response to NSC 638066; 3) Molecule: the relationships between components within communities and NSC 638066; 4) MDR: the compounds that were significantly associated with the NSC 638066.

NSC Compound Enrichment Correlation
NSC 642293 Null 0.0135712240673828 0.35249675
NSC 651852 Null 0.0135712240673828 0.28029415
NSC 668600 Null 0.0135712240673828 0.16443588
NSC 689137 Null 0.0135712240673828 0.51208405
NSC 728319 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.0135712240673828 0.3012268
NSC 731399 2-Benzylthio-4-chloro-5-methyl-N-(2,3-dihydro-1H-benzimidazo l-2-yl)benzenesulfonamide 0.0135712240673828 0.18141346
NSC 95382 Camptothecin Derivative 0.0135712240673828 0.44675465
NSC 19441 FDA 0283 0.0140620887790591 0.097851235
NSC 606869 Clofarabine 0.0140620887790591 0.12018016
NSC 684910 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer B)-, stereoisomer of NSC-684909 0.0140620887790595 -0.21535391
Total:47  Current:13    [First] [Prev] [Next] [Last]